Free shipping on all orders over $ 500

IDO-IN-2 (NLG-919 Analogue)

Cat. No. M2568
IDO-IN-2 (NLG-919 Analogue) Structure
Synonym:

GDC-0919 analogue

Size Price Availability Quantity
10mg USD 105  USD105 In stock
50mg USD 375  USD375 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

NLG919 is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM.

Product Citations
Chemical Information
Molecular Weight 282.38
Formula C18H22N2O
CAS Number 1402836-58-1
Solubility (25°C) DMSO 56 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jian Xu, et al. Eur J Pharm Sci. NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel

[2] Yichao Chen, et al. Mol Pharm. Improved Cancer Immunochemotherapy via Optimal Co-delivery of Chemotherapeutic and Immunomodulatory Agents

[3] Bing Feng, et al. Adv Mater. Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment

Related IDO Products
IDO-IN-18

IDO-IN-18 is an IDO inhibitor.

IDO1-IN-21

IDO1-IN-21 is an IDO1 inhibitor (IC50 = 0.64 μM).

IDO1-IN-22

IDO1-IN-22 is a IDO1 inhibitor (biochemical hIDO1 IC50: 67.4 nM, HeLa hIDO1 IC50: 17.6 nM).

IDO1/TDO-IN-6

IDO1/TDO-IN-6 is a dual inhibitor of IDO1/TDO with IC50s of 2.25 and 2.89 μM, respectively.

IDO-IN-13 

IDO-IN-13 is a potent indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with an EC50 of 17 nM, extracted from patent WO2019040102A1, example 43.

  Catalog
Abmole Inhibitor Catalog




Keywords: IDO-IN-2 (NLG-919 Analogue), GDC-0919 analogue supplier, IDO, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.